All Ma Guanghui articles
-
NewsResearchers develop lysosomal TRAP for clearance of viruses and variants
Researchers have developed a novel lysosomal strategy for clearing viruses and their variants. This lysosomal ‘TRAP’ (lysoTRAP) shows potential for inhibiting infection by viruses and variants in cell, mouse, hamster, and human lung organoid models.
-
NewsResearchers develop probiotic to ameliorate ulcerative colitis
Researchers have developed a probiotic-based therapeutic that synergistically restores intestinal redox and microbiota homeostasis. It relieved inflammation and reduced colonic damage in mouse and non-human primate (NHP) models of colitis.
-
NewsNovel intranasal mask protects respiratory tract from viral aerosols
Researchers have developed a novel intranasal mask to protect the respiratory tract from viral aerosols. It showed satisfactory protection in mouse model, digital human nasal model and human respiratory tract model.
-
News Researchers develop a novel dry-powder inhaled vaccine platform
Researchers have developed a single-dose, dry-powder, inhalable vaccine platform using nano-micro composite multilevel structures, which is effective in blocking respiratory viral infection and transmission in animal models.